Congress Park Capital LLC Amgen Inc Transaction History

Congress Park Capital LLC

$269 Million
Q3 2024

A detailed history of Congress Park Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Congress Park Capital LLC holds 6,595 shares of AMGN stock, worth $1.74 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

6,595

Previous 6,595 -0.0%

Holding current value

$1.74 Million

Previous $2.06 Million 3.11%

% of portfolio

0.79%

Previous 0.83%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $123,680 - $149,297	-460 Reduced 6.52%	6,595 $1.88 Million
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $5,725 - $7,275	-25 Reduced 0.35%	7,055 $1.85 Million
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 0.7%	7,080 $1.6 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $115,355 - $128,370	-500 Reduced 6.55%	7,130 $1.74 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $76,744 - $84,899	-350 Reduced 4.39%	7,630 $1.85 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $119,328 - $136,560	600 Added 8.13%	7,980 $1.8 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $63,681 - $74,610	300 Added 4.24%	7,380 $1.57 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $10,511 - $11,661	-45 Reduced 0.63%	7,080 $1.73 Million
Q4 2020 Jan 19, 2021	SELL	$216.38 - $257.67 $5,409 - $6,441	-25 Reduced 0.35%	7,125 $1.64 Million
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 0.69%	7,150 $1.69 Million
Q4 2018 Feb 06, 2019	SELL	$178.4 - $208.25 $7,136 - $8,330	-40 Reduced 0.55%	7,200 $1.4 Million
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $76,243 - $89,100	-450 Reduced 5.85%	7,240 $1.23 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.3 Million - $1.45 Million	7,690	7,690 $1.34 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Congress Park Capital LLC with notifications on news.

Account

Congress Park Capital LLC Amgen Inc Transaction History